GEM Co., Ltd. (SHE:002340)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	33,347	33,382	28,040	38,157	49,509	33,437
Market Cap Growth	3.35%	19.05%	-26.51%	-22.93%	48.07%	65.46%
Enterprise Value	61,994	57,258	45,732	49,758	59,346	40,523
Last Close Price	6.54	6.46	5.34	7.21	10.01	6.75
PE Ratio	31.09	32.71	30.01	29.45	53.62	81.06
Forward PE	17.91	18.47	16.47	18.58	18.48	30.39
PS Ratio	0.97	1.00	0.92	1.30	2.57	2.68
PB Ratio	1.32	1.42	1.29	1.83	3.13	2.37
P/TBV Ratio	1.86	1.96	1.71	2.34	4.01	2.92
P/OCF Ratio	-	10.93	12.96	-	66.75	39.15
PEG Ratio	-	1.55	1.55	1.55	1.55	1.55
EV/Sales Ratio	1.81	1.73	1.50	1.69	3.08	3.25
EV/EBITDA Ratio	13.58	12.75	22.86	16.73	23.59	23.38
EV/EBIT Ratio	23.74	21.58	74.37	26.16	37.10	43.99
Debt / Equity Ratio	1.15	1.17	0.93	0.77	0.74	0.71
Debt / EBITDA Ratio	6.35	6.14	10.12	5.34	4.61	5.79
Asset Turnover	0.53	0.56	0.63	0.75	0.60	0.44
Inventory Turnover	3.39	3.31	3.46	3.65	2.65	1.80
Quick Ratio	0.45	0.44	0.62	0.76	0.62	0.57
Current Ratio	0.88	0.85	1.11	1.46	1.22	1.11
Return on Equity (ROE)	6.17%	5.88%	5.46%	7.27%	6.43%	3.40%
Return on Assets (ROA)	2.53%	2.78%	0.79%	3.03%	3.12%	2.04%
Return on Capital (ROIC)	3.33%	3.56%	0.97%	3.69%	3.87%	2.49%
Return on Capital Employed (ROCE)	6.40%	7.30%	2.00%	6.50%	7.80%	5.70%
Earnings Yield	3.23%	3.06%	3.33%	3.40%	1.86%	1.23%
FCF Yield	-30.38%	-26.61%	-11.52%	-10.88%	-4.90%	-1.71%
Dividend Yield	1.01%	1.02%	1.50%	0.69%	0.29%	0.22%
Payout Ratio	117.94%	119.85%	107.08%	63.76%	69.01%	188.62%
Buyback Yield / Dilution	-1.83%	1.73%	-4.16%	-2.57%	-6.02%	-12.21%
Total Shareholder Return	-0.82%	2.75%	-2.66%	-1.87%	-5.73%	-11.98%

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.